Clinical Trial Update: Study in Hepatitis C Virus (HCV) Infected Patients Undergoing Liver Transplantation to Evaluate a Human Monoclonal Antibody Against Hepatitis C [Phase 2]

View source ↗

Summary

A Phase 2 study evaluating a human monoclonal antibody against Hepatitis C in HCV-infected patients undergoing liver transplantation was terminated; results wer…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• Human monoclonal antibody against Hepatitis C

Snippet

Sponsor: MassBiologics | Conditions: HCV Infection, Liver Transplantation | Phase 2 | Status: TERMINATED | Results posted: 2016-06-14